JPRN-UMIN000012126
Completed
未知
Study of intravitreal aflibercept for exudative age-related macular degeneration - Intravitreal aflibercept for AMD
Department of Ophthalmology, Jikei University School of Medicine0 sites30 target enrollmentOctober 25, 2013
ConditionsAge-related macular degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Age-related macular degeneration
- Sponsor
- Department of Ophthalmology, Jikei University School of Medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Greatest Linear Dimension (GLD) of the total lesion area \<12 Macular Photocoagulation Study Disc Areas 2\) Presence of subretinal hemorrhage, scar or macular fibrosis (\>50% lesion area) 3\) Prior treatment with anti\-VEGF drug, photodynamic therapy 4\) Prior treatment with dexamethasone (\<6 months) or triamcinolone (\<30 days), intraocular surgery (\<3 months) 5\) Active intraocular inflammation 6\) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 7\) Patient who the doctor in charge judges are ineligible for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Intravitreal aflibercept injection for exudative age-related macular degeneratioAge-Related Macular DegenerationJPRN-UMIN000010997Department of Ophthalmology, Fukushima Medical University School of Medicine50
Completed
Phase 4
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
Completed
Phase 3
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
Active, not recruiting
Phase 1
The Effect of Intravitreal Aflibercept on Ocular Perfusion – a Pilot StudyExudative AMDMedDRA version: 19.1Level: LLTClassification code 10025411Term: Macular degeneration senileSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2016-004608-78-ATKepler University Hospital, Institute of Ophthalmology
Active, not recruiting
Not Applicable
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40